Zhejiang Hisun Biomaterials Co., Ltd. Class A
SSSE:68820315.26
CNY
+0.16
(+1.06%)
ISIN
CNE100005PR6
Return %
Stock
S&P 500
1Y
13.54
14.39
3Y
26.74
81.42
5Y
- -
68.62
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Zhi Ming Chen
- Full Time Employees
- 453
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Taizhou China
- IPO Date
- Aug 16, 2022
- Website
- hisunplas.com
- Similar Companies
- Business
- Zhejiang Hisun Biomaterials Co., Ltd. is a China-based biopolymer company that engages in the research, development, manufacture, and distribution of polylactic acid resins and modified bio-based materials. Founded in August 2004 and headquartered in Taizhou, Zhejiang Province, the company was established through a collaboration involving Zhejiang Hisun Group Co., Ltd., the Changchun Institute of Applied Chemistry of the Chinese Academy of Sciences, and local state-owned asset entities, trading on the Shanghai Stock Exchange STAR Market under ticker 688203. The company operates within the biodegradable materials and bio-plastics industry, developing eco-friendly polymer alternatives to traditional petrochemical plastics through proprietary lactide production, purification, and ring-opening polymerization processes. Zhejiang Hisun Biomaterials Co., Ltd. manufactures and markets a diverse portfolio of bio-based products primarily under the Revode brand name, which includes: virgin polylactic acid resins such as Revode 101, Revode 190, and Revode 201 for standard extrusion, sheet extrusion, and film casting applications; specialized thermoforming-grade resins, including Revode 110, for food packaging, beverage cups, and transparent containers; injection molding resins, including Revode 210, for consumer goods, electronic enclosures, and disposable cutlery; modified polylactic acid compounds engineered for enhanced impact strength, high-temperature resistance, and flexible processing; blown film grade resins for biodegradable shopping bags, courier packaging, and agricultural mulch films; fiber-grade PLA resins and non-woven fabric raw materials for apparel, medical textiles, and hygiene products; and specialized high-purity PLA materials designed for additive manufacturing and consumer 3D printing consumables. The company serves downstream industrial converters, consumer product manufacturers, packaging enterprises, and material distributors across China as well as international markets in Asia, Europe, and North America. In recent developments, Zhejiang Hisun Biomaterials Co., Ltd. has executed significant production expansions, product line adaptations, and operational adjustments to capitalize on expanding industrial demand. The company officially commissioned Phase I of its major polylactic acid expansion project through its wholly owned subsidiary Zhejiang Haichuangda Biomaterials Co., Ltd., bringing 75,000 metric tons of annual capacity online to elevate the company's total production capacity to 125,000 metric tons per year across its Haichuangda and Hainuoer facilities. In response to evolving macroeconomic conditions and technological iterations, the company recalibrated its investment timeline for the Phase II project (75,000 metric tons per year), scheduling completion for late 2028 to integrate advanced equipment and process optimizations. Additionally, the company has strategically expanded sales and product offerings into the rapidly growing consumer 3D printing filament market, strengthened technical collaborations for high-performance lactide derivatives, and implemented corporate governance appointments across its executive management and board leadership.